Closed
28.08 -0.11
24h
Min
28.01
Max
28.39
Income | 28M -13M |
|---|---|
Sales | 33M 114M |
Profit margin | -11.145 |
Employees | 385 |
EBITDA | 13M -13M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +23.91% upside |
Next Earnings | 30 paź 2025 |
|---|
Market Cap | 1.1B 2.5B |
|---|---|
Previous open | 28.19 |
Previous close | 28.08 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 34.77 USD 23.91%
High 47 USD
Low 25 USD
Based on 16 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$